Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Jeffrey Goldberg Seminar in Neuroregeneration

Optic Nerve Regeneration: Uncovering Molecular Pathways

Jeffrey Goldberg

The NEI AGI Seminar Series in Neuroregeneration explores topics relevant to regenerative neuroscience and medicine, with special emphasis on the visual system.

Sept. 25, 2018

Jeffrey Goldberg, M.D., Ph.D., presented “Optic Nerve Regeneration: Uncovering Molecular Pathways,” Tuesday, Sept. 25, 2018, on the NIH campus. His lecture was part of the NEI Audacious Goals Initiative (AGI) Seminar Series in Neuroregeneration. Goldberg is chairman of ophthalmology and director of the Byers Eye Institute at Stanford University. He leads a project funded by the National Eye Institute AGI to identify genes and proteins in mice that help or hinder the regenerative capacity of retinal ganglion cells. These neurons carry signals from the eye, through the optic nerve, and to the brain. Loss of these cells, due to diseases including glaucoma, causes irreversible vision loss. However, recent advances by Goldberg and others suggest therapeutic regeneration of retinal ganglion cells may be possible. Goldberg summarized his recent AGI work and highlighted recent progress in neuroregeneration of the visual system.

See more AGI events and reports

Last updated: December 31, 2024